[1]
“QUALITY BY DESIGN APPROACH FOR RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF CABOTEGRAVIR FROM BULK DRUG AND DOSAGE FORM”, Int. J. Pharm. Sci. Drug Res., vol. 17, no. 3, pp. 243–252, May 2025, doi: 10.25004/IJPSDR.2025.170304.